Emmanuel J Favaloro/LinkedIn
Jan 9, 2026, 07:19
Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared on LinkedIn:
”100 years of von Willebrand disease (VWD).
2026 marks the 100th year anniversary of the initial publication of a bleeding disorder “pseudo-hemophilia’ that was later to become known as von Willebrand disease.
Seminars in Thrombosis and Hemostasis will publish several papers on VWD in 2026.
This is the first one in queue – on type 2A VWD.
Enjoy!”
Read the full article here.
Article: Von Willebrand Disease Type 2A: An Update
Authors: Omid Seidizadeh , Luciano Baronciani , Pier Mannuccio Mannucci , Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch